Search our news, events & opinions

5 December 2018 0 Comments
Posted in Case Studies, Corporate & Commercial

Negotiation, drafting and review of a contract for a new orphan drug

Posted by , Partner

Long standing client from charity sector with a patient data base, came to us with the need for legal advice. It had been approached by a European Pharmaceutical, (EP). EP wanted to have access to our client’s database in order …

Long standing client from charity sector with a patient data base, came to us with the need for legal advice. It had been approached by a European Pharmaceutical, (EP).

EP wanted to have access to our client’s database in order to obtain approval for their new orphan drug developed to treat patients suffering from a particular syndrome.

We assisted the client with the negotiation, drafting and review of a contract with EP and a German service provider. Because of the nature of the personal information in the database, we had to take the following issues into account:

1. Data protection, including GDPR;
2. Cross Border issues;
3. The drafting of a contract which gave our client the best possible protection.

The contract was agreed in June 2018.

For further information, please contact Claus Andersen at Royds Withy King on:

020 7853 2222     Email usclaus.andersen@roydswithyking.com

Leave a comment

Thank you for choosing to leave a comment. Please keep in mind that comments are moderated and please do not use a spammy keyword or a domain as your name or it will be deleted.

*required*

**required*

*optional*

Case Studies

Learn more

Partner

T: 020 7842 1462 (DDI)
Email

Search our news, events & opinions